Safety considerations in IGIV utilization

International Immunopharmacology

Volumn 6, Issue 4, 2006, Pages 523-527

  Siegel, Jerry ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

IGIV; Osmolality; Safety; Tolerability; Viral transmission

Indexed keywords

AMINO ACID; CARIMUNE; GAMUNEX; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PANGLOBULIN; SODIUM CHLORIDE; SUGAR;

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; COMORBIDITY; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG SAFETY; DRUG STABILITY; DRUG TOLERABILITY; DRUG UTILIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; INFECTION RISK; KIDNEY DISEASE; KIDNEY FUNCTION; NEPHROSIS; OSMOLALITY; PRIORITY JOURNAL; REVIEW; SLOW DRUG RELEASE; VIRUS INACTIVATION; VIRUS TRANSMISSION;

EID: 33644537028     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.11.004     Document Type: Article

References (12)

1. D.S. Gordon Intravenous immunoglobulin: historical perspective Am J Med 83 suppl.4A 1987 1 3
2. H. Nielson Immunoglobulin preparations for intravenous administration. A review of their biologic activities and comparison of various preparation methods Allergy 49 1994 69 73
3. A.W. Burks, H.A. Sampson, and R.H. Buckley Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia NEJM 314 1986 560 564
4. E. Tan, M. Hajinazarian, W. Bay, J. Neff, and J.R. Mendell Acute renal failure resulting from intravenous immunoglobulin therapy Arch Neurol 50 1993 137 139
5. ASHP therapeutic guidelines for intravenous immune globulin. ASHP commission on therapeutics Clin Pharm 11 1992 117 136
6. Epidemiologic notes and reports outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States, October 1993-June 1994 MMWR 43 1994 505 509
7. Non-A, non B hepatitis and intravenous immunoglobulin [Letter] Lancet 1 1985 404 405
8. P. Schiff, and A. Kemp Safety of IVIG made from HCV-antibody screened plasma [Letter] Lancet 338 1991 1076
9. R.R. Nixon, S.A. Smith, R.L. Johnson, and D.E. Pillers Misleading hepatitis C serology following administration of intravenous immunoglobulin Am J Clin Pathol 101 1994 327 328
10. J.M. Romeo, P.P. Ulrich, M.P. Busch, and G.N. Vyas Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors Hepatology 17 1993 188 195
11. P. Hellstern, H. Sachse, H. Schwinn, and K. Oberfrank Manufacture and in vitro characterization of a solvent/detergent-treated human plasma Vox Sang 63 1992 178 185
12. J. Siegel Pharmaceutical considerations and therapeutic issues related to intravenous immune globulin use Pharmacy Practice News Special Edition vol. 9 2004 Oct 65 69